Skip to content

Comparison Study Between C13-CAC Breath Test and 24-hour Gastric pH Monitoring

Unblinded Comparison Study for Relationship and Reproducibility Between C13-CAC Breath Test and 24-hour Gastric pH Monitoring, in Patients With Acid-related Diseases and Healthy Volunteers

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02225067
Enrollment
40
Registered
2014-08-25
Start date
2014-08-31
Completion date
2014-12-31
Last updated
2015-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Acid-related Diseases, Healthy

Keywords

Patients, Volunteers

Brief summary

The purpose of this study is to compare C13-CAC Breath Test with 24-hour Gastric pH Monitoring in Patients with Gastric Acid-related Diseases and Healthy Volunteers

Interventions

Visit 1 and Visit 2, 24-hour gastric pH monitoring and C13-CAC breath test containing 200 mg of Calcium (13C)Carbonate

Sponsors

EPS Corporation
CollaboratorOTHER
Otsuka Pharmaceutical Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with Gastric Acid-related diseases like peptic ulcer or gastroesophageal reflux disease in investigator's judgment * Healthy subjects who are determined no history of Helicobacter pylori infections

Exclusion criteria

* Patients with hypercalcemia * Patients with hypothyroidism * Patients with hyperparathyroidism * History of upper gastrointestinal surgery or resection * Any condition would limit the subject's ability to complete 24-hour gastric pH monitoring

Design outcomes

Primary

MeasureTime frameDescription
13CO2 concentration in expired air5,10,15,20,25,30,40,50,60,80,100 and 120minutes after C13-CAC administration13CO2 concentration in expired air, 13CO2 excretion rate in expired air as well as the pharmacokinetic parameters (Cmax, AUCt, AUC∞, tmax, λz, and t1/2) determined from the 13CO2 concentration in expired air and 13CO2 excretion rate in expired air
24-hour gastric pHfrom completion of pre-study examination to before C13-CAC adminitrationGastric pH immediately before taking the C13-CAC and mean gastric pH from a specified time point to the time before C13-CAC administration

Other

MeasureTime frameDescription
Gastric pH holding time ratiofrom completion of pre-study examination to before C13-CAC adminitrationpH 3 holding time ratio and pH 4 holding time ratio in the 24-hour gastric pH monitoring

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026